Related Experiment Video
Updated: Nov 15, 2025

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
Thrombocytopenia in Virus Infections
Matthijs Raadsen1, Justin Du Toit2, Thomas Langerak1
1Department of Viroscience, Erasmus MC Rotterdam, Doctor molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
Viral infections often cause thrombocytopenia (low platelet count). This review explores how platelets actively participate in antiviral immunity, challenging the view of them as passive bystanders and aiding in understanding viral disease pathogenesis.
Area of Science:
- Virology
- Hematology
- Immunology
Background:
- Thrombocytopenia, a low platelet count, frequently accompanies viral infections.
- Traditionally, thrombocytopenia in viral infections is explained by platelet consumption, sequestration, or impaired production.
- These explanations often overlook platelets' active role in immune responses.
Purpose of the Study:
- To review the mechanisms linking thrombocytopenia and viral infections.
- To highlight the active role of platelets in antiviral immunity.
- To discuss the implications for understanding viral pathogenesis and predicting outcomes.
Main Methods:
- Literature review of studies on thrombocytopenia and viral infections.
- Analysis of mechanisms involving platelet consumption, sequestration, and production defects.
- Examination of platelet interactions with immune cells and viruses.
Main Results:
- Platelets are not passive bystanders but actively participate in antiviral immune responses.
- Platelets interact with innate and adaptive immune cells and directly with viruses.
- Understanding these interactions is crucial for viral disease pathogenesis and outcome prediction.
Conclusions:
- The relationship between thrombocytopenia and viral infections is complex, involving active platelet immunity.
- Platelets' role extends beyond passive consumption to active immune modulation.
- Further research into platelet-virus interactions can improve understanding and management of viral diseases.
More Related Videos
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
08:52Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Venous Thrombosis I: Introduction
Pharmacokinetics: Drug–Food and Drug–Viral Interactions